Progesterone receptor loss identifies hormone receptor-positive and HER2-negative breast cancer subgroups at higher risk of relapse: a retrospective cohort study.

Onco Targets Ther · 2016 · PMC4807933 · PMID 27051305

Europe PMC DOI

hedged sentence

0.0650

closest p · 1.3× alpha

0.0650

boldest claim

The sentences

marginally significantP =0.065so close (0.05 < p ≤ 0.1)

A marginally significant difference in DFS between the PR− and PR+ disease was seen in postmenopausal patients (log rank P =0.065).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.